Filter
272
Text search:
leprosy
Featured
Recommendations
39
New Publications
92
Language
Document type
No document type
176
Studies & Reports
31
Guidelines
24
Manuals
15
Strategic & Response Plan
15
Training Material
4
Brochures
2
Resource Platforms
2
Fact sheets
2
Situation Updates
1
Countries / Regions
India
31
Kenya
15
Nepal
9
Tanzania
9
Sierra Leone
8
Bangladesh
8
Ethiopia
7
Uganda
6
Rwanda
6
Global
6
Liberia
5
Cambodia
5
Malawi
4
Myanmar / Burma
4
Africa
4
Namibia
3
Nigeria
2
Ghana
2
Zimbabwe
2
Philippines
2
Zambia
2
South Africa
2
Guinea
1
Congo, Democratic Republic of
1
Pakistan
1
South Sudan
1
Jordan
1
Afghanistan
1
Indonesia
1
Papua New Guinea
1
Sudan
1
Benin
1
Madagascar
1
Lesotho
1
Sri Lanka
1
Middle East and North Africa
1
South–East Asia Region
1
Eastern Europe and Central Asia
1
Western and Central Europe
1
Bhutan
1
Timor Leste/ East Timor
1
Russia
1
Authors & Publishers
Publication Years
Category
Countries
128
Clinical Guidelines
33
Public Health
12
Pharmacy & Technologies
7
Key Resources
5
Women & Child Health
4
Capacity Building
3
Annual Report MEDBOX
1
Toolboxes
NTDs
60
TB
44
Disability
21
AMR
6
Pharmacy
5
Ebola & Marburg
4
HIV
4
Polio
3
Rapid Response
3
NCDs
3
Mental Health
2
Social Ethics
2
Planetary Health
2
Cholera
1
Conflict
1
Natural Hazards
1
Specific Hazards
1
COVID-19
1
Caregiver
1
2.0 Rapid Response
1
BMC International Health and Human Rights 2012, 12 :12
http://www.biomedcentral.com/1472-698X/12/12
The meeting of leprosy programme managers in the South-East (SE) Asia Region was convened by the WHO Regional Office for South-East Asia (WHO-SEARO) from 11 to 13 April 2023 in Kolkata, India. The meeting was attended by 40 participants, including 1
...
In case of resistance to rifampicin, fluoroquinolones become the preferred category of second-line drugs. Unfortunately, quinolone-resistant strains of Mycobacterium leprae have also been reported in several countries, probably due to the extensive use of quinolones for treating several types of inf
...
The International Textbook of Leprosy is dedicated to the physicians and health workers caring for their first patient with leprosy, and to all of those in the research community who have encountere
...
Course contents: What is Leprosy? Leprosy is a disease caused by a micro-organism called Mycobacterium leprae
Leprosy will be eliminated when we detect all patients and cure them by using multidrug therapy (MDT).
Elimination means bringing the disease burden down to a very low level. This will lead to a reduction in the source of infection, so that
...
The Leprosy Programme and Transmission Assessment (LPTA) is an activity that is carried out by internal teams towards the end of Phase 1 (see Leprosy Elimination Framework in the Annex) when a subna
...
GUIDELINES ON LEPROSY CONTROL IN SOUTH AFRICA | 2011
A Guide for Low Resource Situations
The Guidelines for the Diagnosis, Treatment and Prevention of Leprosy provide state-of-the-art knowledge and evidence on leprosy diagnosis, treatment and prevention based on a public health approach
...
This booklet is recommended for all health workers who diagnose and treat leprosy, especially those at the first referral level such as a health centre. It contains more detail than the WHO Guide to Eliminate
...
The World Health Organization organized a Consultation of National Leprosy Programme managers, partners and affected persons to discuss the draft Global Leprosy Strategy, 2021--2030. This virtual ev
...
